Reaction

Status Migrainosus reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 150 reports · 3 co-occurring drugs

As of the last recalculation, Status Migrainosus appears in 150 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FREMANEZUMAB-VFRM (PRR 129.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fremanezumab-Vfrm10129.4129.5
Eptinezumab-Jjmr578.878.9
Erenumab-Aooe1129.829.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.